Pulmonary Infection Caused by Mycobacterium malmoense in a Chronic HIV-Infected Individual Participating in a Therapeutic Vaccine Trial

Joana Silva Marques; Marta Bodro; Berta Torres; Felipe García; José Antonio Martínez; Lorna Leal

doi:10.3390/vaccines9101103

Pulmonary Infection Caused by Mycobacterium malmoense in a Chronic HIV-Infected Individual Participating in a Therapeutic Vaccine Trial

Vaccines (Basel). 2021 Sep 29;9(10):1103. doi: 10.3390/vaccines9101103.

Authors

Joana Silva Marques^{1

2}, Marta Bodro¹, Berta Torres¹, Felipe García¹, José Antonio Martínez¹, Lorna Leal¹

Affiliations

¹ Infectious Diseases Department, Hospital Clinic Barcelona, University of Barcelona, 08036 Barcelona, Spain.
² Internal Medicine Department, Centro Hospitalar Tondela-Viseu, 3504-509 Viseu, Portugal.

Abstract

We report a case of Mycobacterium malmoense pulmonary infection and HIV-1 chronic co-infection in a 60-year-old man while participating in an HIV-1 therapeutic vaccine clinical trial and during the analytical treatment interruption. We present clinical and therapeutic features of a complicated M. malmoense pulmonary infection along with discussion of the possible relation to the HIV-1 cure-related interventions.

Keywords: HIV; Mycobacterium malmoense; therapeutic vaccine.

Publication types

Case Reports